Treatment of greasy skin with a bacterial lystate

US9782611B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9782611-B2
Application numberUS-60717009-A
CountryUS
Kind codeB2
Filing dateOct 28, 2009
Priority dateOct 28, 2008
Publication dateOct 10, 2017
Grant dateOct 10, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to the cosmetic treatment of greasy skin and/or skin that tends to be greasy with a lysate of at least one microorganism of the genus Bifidobacterium species and/or a fraction thereof, as an active.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method for treating skin, the method comprising: administering to an individual in need thereof, an effective amount of a whole lysate of at least one microorganism of the genus Bifidobacterium selected from the group consisting of Bifidobacterium longum, Bifidobacterium bifidum; Bifidobacterium breve, Bifidobacterium animalis, Bifidobacterium infantis, Bifidobacterium adolescentis , and Bifidobacterium pseudocatenulatum; wherein the skin treated is at least one selected from the group consisting of a greasy skin, a skin that tends to be greasy and a skin having a disorder associated with greasy skin or skin that tends to be greasy, and wherein the whole lysate is obtained by ultrasonic disintegration and comprises released cytoplasmic fractions, fragments of cell wall and metabolic products. 2. The method according to claim 1 , wherein the treated skin has a skin disorder and the skin disorder is a lesion or imperfection of greasy skin or skin that tends to be greasy, a retention lesion of the open comedo type, or a retention lesion of the closed comedo type. 3. The method according to claim 1 , wherein the treated skin has a skin disorder and the skin disorder is at least one skin imperfection selected from the group consisting of sallow, glistening skin, muddy skin, dyschromia, redness, rough skin, and a plaque of dry skin. 4. The method according to claim 1 , wherein the treated skin has a skin disorder and the skin disorder is seborrhoeic dermatosis. 5. A method for controlling seborrhea, the method comprising administering to an individual in need thereof a composition comprising, an effective amount of a whole lysate of at least one microorganism of the genus Bifidobacterium selected from the group consisting of Bifidobacterium longum, Bifidobacterium bifidum, Bifidobacterium breve, Bifidobacterium animalis, Bifidobacterium infantis, Bifidobacterium adolescentis, Bifidobacterium pseudocatenulatum, wherein the seborrhea is of a greasy skin, a skin that tends to be greasy or a skin having a disorder associated with greasy skin or skin that tends to be greasy, and wherein the whole lysate is obtained by ultrasonic disintegration and comprises released cytoplasmic fractions, fragments of cell wall and metabolic products. 6. The method according to claim 1 , 4 or 5 , wherein the microorganism of the genus Bifidobacterium is Bifidobacterium longum. 7. The method according to claim 1 , 4 or 5 , wherein a content of active substance(s) in the whole lysate is from 0.1 to 50% by weight. 8. The method according to claim 1 , further comprising: administering with the whole lysate another microorganism, probiotic or a fraction thereof, different from the whole lysate. 9. The method according to claim 4 , further comprising: administering with the whole lysate, another microorganism, probiotic or a fraction thereof, different from the whole lysate. 10. The method according to claim 5 , further comprising: administering with the whole lysate, another microorganism, probiotic or a fraction thereof, different from the whole lysate. 11. The method according to claim 8 , wherein a probiotic microorganism different from the whole lysate is administered and the probiotic microorganism is at least one ascomycete microorganism selected from the group consisting of Saccharomyces, Yarrowia, Kluyveromyces, Torulaspora, Schizosaccharomyces pombe, Debaryomyces, Candida, Pichia, Aspergillus and Penicillium , bacteria of the genus Bacteroides, Fusobacterium, Melissococcus, Propionibacterium, Enterococcus, Lactococcus, Staphylococcus, Peptostreptococcus, Bacillus, Pediococcus, Leuconostoc, Weissella, Aerococcus , and Oenococcus. 12. The method according to claim 9 , wherein a probiotic microorganism different from the whole lysate is administered and the probiotic microorganism is at least one ascomycete microorganism selected from the group consisting of Saccharomyces, Yarrowia, Kluyveromyces, Torulaspora, Schizosaccharomyces pombe, Debaryomyces, Candida, Pichia, Aspergillus and Penicillium , bacteria of the genus Bacteroides, Fusobacterium, Melissococcus, Propionibacterium, Enterococcus, Lactococcus, Staphylococcus, Peptostreptococcus, Bacillus, Pediococcus, Leuconostoc, Weissella, Aerococcus , and Oenococcus. 13. The method according to claim 10 , wherein a probiotic microorganism different from the whole lysate is administered and the probiotic microorganism is at least one ascomycete microorganism selected from the group consisting of Saccharomyces, Yarrowia, Kluyveromyces, Torulaspora, Schizosaccharomyces pombe, Debaryomyces, Candida, Pichia, Aspergillus and Penicillium , bacteria of the genus Bacteroides, Fusobacterium, Melissococcus, Propionibacterium, Enterococcus, Lactococcus, Staphylococcus, Peptostreptococcus, Bacillus, Pediococcus, Leuconostoc, Weissella, Aerococcus , and Oenococcus. 14. The method according to claim 1 , 4 or 5 , wherein the whole lysate is administered topically. 15. The method according to claim 1 , 4 or 5 , wherein the whole lysate is in a composition that is in the form of an aqueous solution, an aqueous-alcoholic solution, an oily solution, a solution dispersion, a lotion dispersion, a serum dispersion, an O/W emulsion, an W/O emulsion, a cream, an aqueous gel, an anhydrous gel, a microemulsion, a microcapsule, a microparticle, or a vesicular dispersion.

Assignees

Inventors

Classifications

  • Drugs for dermatological disorders · CPC title

  • Antiseborrheics · CPC title

  • Anti-acne agents · CPC title

  • A61K8/99Primary

    from microorganisms other than algae or fungi, e.g. protozoa or bacteria · CPC title

  • Fungi, e.g. yeasts · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9782611B2 cover?
The present invention relates to the cosmetic treatment of greasy skin and/or skin that tends to be greasy with a lysate of at least one microorganism of the genus Bifidobacterium species and/or a fraction thereof, as an active.
Who is the assignee on this patent?
Gueniche Audrey, Castiel Isabelle, Bernard Dominique, and 1 more
What technology area does this patent fall under?
Primary CPC classification A61K8/99. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).